3,632
edits
Sickle Cell Disease: Difference between revisions
no edit summary
No edit summary |
No edit summary |
||
| Line 29: | Line 29: | ||
[https://www.apsf.org/article/preoperative-transfusion-and-sickle-cell-disease-in-the-pediatric-patient/ APSF: Preoperative Transfusion and Sickle Cell Disease in the Pediatric Patient] | [https://www.apsf.org/article/preoperative-transfusion-and-sickle-cell-disease-in-the-pediatric-patient/ APSF: Preoperative Transfusion and Sickle Cell Disease in the Pediatric Patient] | ||
Firth PG, McMillan KN, Haberkern CM, Yaster M, Bender MA, Goodwin SR. A survey of perioperative management of sickle cell disease in North America. PaediatrAnaesth 2011;21(1):43-49. | |||
2. Goodwin SR, Haberkern C, Crawford M, Lerman J, Mancuso T, Yaster M. Sickle cell and anesthesia: do not abandon well-established practices without evidence. Anesthesiology 2005;103(1):205-207. | |||
3. Vichinsky EP, Haberkern CM, Neumayr L, et al. A comparison of conservative and aggressive transfusion regimens in the perioperative management of sickle cell disease. The Preoperative Transfusion in Sickle Cell Disease Study Group [see comments]. NEnglJMed 1995;333(4):206-213. | |||
4. Azbell RCG, Lanzkron SM, Desai PC. Current Evidence and Rationale to Guide Perioperative Management, Including Transfusion Decisions, in Patients With Sickle Cell Disease. Anesthesia and analgesia 2023;136(6):1107-1114. (In eng). DOI: 10.1213/ane.0000000000006463. | |||
5. Baijal RG, Dalal PG, Kanjia M. Preoperative Transfusion and Sickle Cell Disease in the Pediatric Patient. Anesthesia Patient Safety Foundation. 06/2024 (https://www.apsf.org/article/preoperative-transfusion-and-sickle-cell-disease-in-the-pediatric-patient/?utm_source=APSF+Newsletter+Email+-+External&utm_medium=email&utm_campaign=EMAIL_CAMPAIGN_2024_06_01). | |||
6. Hyder O, Yaster M, Bateman BT, Firth PG. Surgical procedures and outcomes among children with sickle cell disease. Anesthesia and analgesia 2013;117(5):1192-6. (In eng). DOI: 10.1213/ANE.0b013e3182a44d74. | |||
7. Waldron P, Pegelow C, Neumayr L, et al. Tonsillectomy, adenoidectomy, and myringotomy in sickle cell disease: perioperative morbidity. Preoperative Transfusion in Sickle Cell Disease Study Group. JPediatrHematolOncol 1999;21(2):129-135. | |||
8. Chou ST, Alsawas M, Fasano RM, et al. American Society of Hematology 2020 guidelines for sickle cell disease: transfusion support. Blood Adv 2020;4(2):327-355. (In eng). DOI: 10.1182/bloodadvances.2019001143. | |||
9. Salvi PS, Solomon DG, Cowles RA. Preoperative Transfusion and Surgical Outcomes for Children with Sickle Cell Disease. J Am Coll Surg 2022;235(3):530-538. (In eng). DOI: 10.1097/xcs.0000000000000267. | |||
10. Pignatti M, Zanella S, Borgna-Pignatti C. Can the surgical tourniquet be used in patients with sickle cell disease or trait? A review of the literature. Expert Rev Hematol 2017;10(2):175-182. (In eng). DOI: 10.1080/17474086.2017.1273765. | |||